B cells can also facilitate expansion of CD8 and CD4 T cells specific for tumor-associated antigens [37], thanks to their ability to present (through MHC class II) or cross-present (through MHC class I) epitopes independent of their B-cell receptor (BCR) specificity [38]. The gene discussed is BCR; the disease is neoplasm.